These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19809508)

  • 1. Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.
    Leypoldt F; Choe CU; Gelderblom M; von Leitner EC; Atzler D; Schwedhelm E; Gerloff C; Sydow K; Böger RH; Magnus T
    PLoS One; 2009 Oct; 4(10):e7337. PubMed ID: 19809508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
    Konishi H; Sydow K; Cooke JP
    J Am Coll Cardiol; 2007 Mar; 49(10):1099-105. PubMed ID: 17349891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
    Dayoub H; Achan V; Adimoolam S; Jacobi J; Stuehlinger MC; Wang BY; Tsao PS; Kimoto M; Vallance P; Patterson AJ; Cooke JP
    Circulation; 2003 Dec; 108(24):3042-7. PubMed ID: 14638548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.
    Tanaka M; Sydow K; Gunawan F; Jacobi J; Tsao PS; Robbins RC; Cooke JP
    Circulation; 2005 Sep; 112(11):1549-56. PubMed ID: 16144995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.
    Zhao Y; Ma X; Zhou Y; Xie J; Liu X; Zhao Y
    Lab Invest; 2021 Jul; 101(7):808-823. PubMed ID: 33574439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.
    Jacobi J; Sydow K; von Degenfeld G; Zhang Y; Dayoub H; Wang B; Patterson AJ; Kimoto M; Blau HM; Cooke JP
    Circulation; 2005 Mar; 111(11):1431-8. PubMed ID: 15781754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F; Onozato ML; Luo Z; Wilcox CS
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
    Jacobi J; Maas R; Cardounel AJ; Arend M; Pope AJ; Cordasic N; Heusinger-Ribeiro J; Atzler D; Strobel J; Schwedhelm E; Böger RH; Hilgers KF
    Am J Pathol; 2010 May; 176(5):2559-70. PubMed ID: 20348244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
    Wang D; Gill PS; Chabrashvili T; Onozato ML; Raggio J; Mendonca M; Dennehy K; Li M; Modlinger P; Leiper J; Vallance P; Adler O; Leone A; Tojo A; Welch WJ; Wilcox CS
    Circ Res; 2007 Sep; 101(6):627-35. PubMed ID: 17673667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
    Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S; Laguna-Fernández A; Lázaro-Franco M; Sobrino A; Bueno-Betí C; Tarín JJ; Monsalve E; Sanchís J; Hermenegildo C
    Mol Cell Endocrinol; 2013 Jan; 365(1):11-6. PubMed ID: 22982060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.